Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05945550 · ClinicalTrials.gov registry record

Comparison of Complication Rates Between Initial and Re-operative Anterior Lumbar Interbody Fusion Surgery: Is There a Difference?

A clinical trial of Lumbar Spine Degeneration and Lumbar Spondylolisthesis, sponsored by Methodist Health System.

Active
Registry status
3,500
Enrollment target
1
Study location

NCT05945550: Active study of Lumbar Spine Degeneration and Lumbar Spondylolisthesis, sponsored by Methodist Health System.

NCT05945550 is a study of Lumbar Spine Degeneration and Lumbar Spondylolisthesis that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 3,500 participants, above the 144-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (2331% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05945550, a study of Lumbar Spine Degeneration and Lumbar Spondylolisthesis, is active but no longer recruiting, sponsored by Methodist Health System.

ACTIVE NOT RECRUITING
Registry status
3,500 participants
Enrollment target
1
Study location

Study Summary

To identify the current mortality rate for initial Anterior Lumbar Interbody Fusion(ALIF)procedures. Establish/prove mortality rates for this operation have dropped in the past decade.

Primary Outcome

Establish mortality rates of patients for this operation have dropped in the past decade.

Study Locations (1)

Texas

  • Methodist Dallas Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 3,500 participants
Start Date 2020-12-28
Est. Completion 2028-12-28
Methodist Health System

125 total trials

What the registry record for NCT05945550 still lists

NCT05945550 is an observational study that tracks outcomes without assigning an intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus, above the 144-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (2331% higher).

The record links to 2 conditions, with Lumbar Spine Degeneration appearing as the primary indexed condition, and to 0 interventions.

NCT05945550 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05945550 about?

NCT05945550 is a clinical study titled "Comparison of Complication Rates Between Initial and Re-operative Anterior Lumbar Interbody Fusion Surgery: Is There a Difference?". To identify the current mortality rate for initial Anterior Lumbar Interbody Fusion(ALIF)procedures. Establish/prove mortality rates for this operation have dropped in the past decade.

What is the current status of trial NCT05945550?

This trial is currently active not recruiting. The enrollment target is 3,500 participants. The study started on 2020-12-28. Estimated completion is 2028-12-28.

What conditions does trial NCT05945550 study?

This clinical trial studies the following conditions: Lumbar Spine Degeneration, Lumbar Spondylolisthesis.

Who is sponsoring clinical trial NCT05945550?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05945550 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lumbar Spine Degeneration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00260559 · 3,500 participants

    Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

  • NCT01612949 · 3,500 participants

    Facial Analysis to Classify Difficult Intubation

  • NCT02398786 · 3,500 participants

    Myotonic Dystrophy Family Registry

  • NCT03486873 · 3,500 participants · Phase 3

    Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05945550, the US trial registry maintained by the National Library of Medicine. NCT05945550 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.